Combination therapy with cyclophosphamide, vincristine, procarbazine and prednisone in Hodgkin's disease and reticulum cell sarcoma.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000963:Antimetabolites / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D014750:Vincristine / Q000627:therapeutic use*
D000963:Antimetabolites; D001565:Benzoates; D014750:Vincristine; D003520:Cyclophosphamide; D011241:Prednisone